Published on Medical Design Technology (http://www.mdtmag.com)

Home > St. Jude Medical seesaws on FDA warning letter

St. Jude Medical seesaws on FDA warning letter

Mass Device

Wall Street investors send shares of St. Jude Medical up yesterday and down today after the company reveals a warning letter from the FDA over its Sylmar, Calif., Durata defibrillator lead plant.

MassDevice.com Wall Street Beat

A warning letter from the FDA to St. Jude Medical [1] (NYSE:STJ [2]) sent the St. Paul, Minn.-based medical device company's stock on a seesaw ride yesterday and today.

STJ shares closed up 1.5% yesterday at $38.85 each after St. Jude revealed the warning letter, but closed down 1.2% today at $38.39 apiece.

 

Source URL (retrieved on 05/23/2013 - 10:50am): http://www.mdtmag.com/news/2013/01/st-jude-medical-seesaws-fda-warning-letter

Links:
[1] http://www.massdevice.com/company/st-jude-medical
[2] http://www.google.com/finance?q=stj